Cleared Traditional

K192276 - Merge Cardio (FDA 510(k) Clearance)

Sep 2019
Decision
29d
Days
Class 2
Risk

K192276 is an FDA 510(k) clearance for the Merge Cardio. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Merge Healthcare Incorporated (Hartland, US). The FDA issued a Cleared decision on September 20, 2019, 29 days after receiving the submission on August 22, 2019.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K192276 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 22, 2019
Decision Date September 20, 2019
Days to Decision 29 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ — System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050